Orilissa
Drug
AbbVie, Inc.
Total Payments
$43.0M
Transactions
105,235
Doctors
18,741
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $32.3M | 76,029 | 16,351 |
| 2018 | $10.6M | 29,206 | 12,113 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $31.9M | 9,135 | 74.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7.6M | 3,528 | 17.6% |
| Food and Beverage | $2.1M | 87,629 | 4.9% |
| Travel and Lodging | $1.2M | 4,241 | 2.9% |
| Consulting Fee | $80,113 | 24 | 0.2% |
| Space rental or facility fees (teaching hospital only) | $38,575 | 26 | 0.1% |
| Education | $4,623 | 652 | 0.0% |
Payments by Type
Research
$31.9M
9,135 transactions
General
$11.0M
96,100 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| M16-283 | AbbVie, Inc. | $15.1M | 5 |
| M14-702 | AbbVie, Inc. | $10.6M | 5 |
| M12-816 | AbbVie, Inc. | $1.6M | 4 |
| M16-856 | AbbVie, Inc. | $1.5M | 0 |
| F16-974 | AbbVie, Inc. | $945,911 | 0 |
| M12-815 | AbbVie, Inc. | $890,656 | 2 |
| M12-817 | AbbVie, Inc. | $725,171 | 2 |
| M16-383 | AbbVie, Inc. | $500,224 | 1 |
| M16-824 | AbbVie, Inc. | $12,460 | 2 |
| M12-665 | AbbVie, Inc. | $11,461 | 0 |
| M12-821 | AbbVie, Inc. | $9,027 | 0 |
| M12-667 | AbbVie, Inc. | $6,650 | 0 |
| M16-837 | AbbVie, Inc. | $6,450 | 1 |
| M12-813 | AbbVie, Inc. | $4,135 | 0 |
| M12-671 | AbbVie, Inc. | $836.64 | 0 |
Top Doctors Receiving Payments for Orilissa — Page 750
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Obstetrics & Gynecology | Kirkland, WA | $3.85 | 1 |
| , MD | Obstetrics & Gynecology | Shelby, NC | $3.85 | 1 |
| , M.D | Obstetrics & Gynecology | Salem, NH | $3.85 | 1 |
| , M.D | Obstetrics & Gynecology | Mount Vernon, WA | $3.85 | 1 |
| , MD | Obstetrics & Gynecology | Camden, SC | $3.85 | 1 |
| , MD | Obstetrics & Gynecology | Bellingham, WA | $3.85 | 1 |
| , MD | Gynecology | Brevard, NC | $3.85 | 1 |
| , MD | Obstetrics & Gynecology | Wayne, NJ | $3.85 | 1 |
| , M.D | Gynecology | Murrieta, CA | $3.85 | 1 |
| , M.D | Obstetrics & Gynecology | Orlando, FL | $3.85 | 1 |
| , MD | Obstetrics & Gynecology | Huntington, NY | $3.75 | 1 |
| , MD | Obstetrics & Gynecology | Pittsfield, MA | $3.31 | 1 |
| , DO | Obstetrics & Gynecology | Clovis, CA | $3.05 | 1 |
| Enrique Decastro | — | Portland, OR | $3.04 | 1 |
| , MD | Obstetrics & Gynecology | Boston, MA | $2.80 | 1 |
| , MD | Gynecology | Saint Cloud, FL | $1.98 | 1 |
| , MD | Obstetrics & Gynecology | Saint Louis, MO | $1.81 | 1 |
Ad
Manufacturing Companies
- AbbVie, Inc. $43.0M
- AbbVie Inc. $170.28
Product Information
- Type Drug
- Total Payments $43.0M
- Total Doctors 18,741
- Transactions 105,235
About Orilissa
Orilissa is a drug associated with $43.0M in payments to 18,741 healthcare providers, recorded across 105,235 transactions in the CMS Open Payments database. The primary manufacturer is AbbVie, Inc..
Payment data is available from 2018 to 2019. In 2019, $32.3M was paid across 76,029 transactions to 16,351 doctors.
The most common payment nature for Orilissa is "Unspecified" ($31.9M, 74.3% of total).
Orilissa is associated with 15 research studies, including "M16-283" ($15.1M).